Search Results - P.J. Ho

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    PB2035: CAMMA 3: A MULTICENTER PHASE IB TRIAL EVALUATING THE SAFETY, PHARMACOKINETICS, AND ACTIVITY OF SUBCUTANEOUS CEVOSTAMAB MONOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY M... by S. Delimpasi, H. Quach, M. Cavo, P. J. Ho, C. H.-S. Lee, A. Santoro, R. Schots, P. Vlummens, D. H. Yoon, S.-S. Yoon, C. D. Santos, D. Samineni, J. Huang, K. Wehrman, U. Patil, S. Sheikh, M. A. Dimopoulos

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  2. 2

    S262: THE COBALT-LYM STUDY OF CTX130: A PHASE 1 DOSE ESCALATION STUDY OF CD70-TARGETED ALLOGENEIC CRISPR-CAS9–ENGINEERED CAR T CELLS IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) T-CE... by S. P. Iyer, R. A. Sica, P. J. Ho, B. Hu, J. Zain, A. Prica, W.-K. Weng, Y. H. Kim, M. S. Khodadoust, M. L Palomba, F. M. Foss, K. Tipton, E. L. Cullingford, Q. He, A. Sharma, S. M. Horwitz

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  3. 3

    DP110 | INFECTIONS AND IMMUNE RECONSTITUTION IN THE PHASE 3 CARTITUDE-4 TRIAL OF CILTACABTAGENE AUTOLEUCEL VS STANDARD CARE IN LENALIDOMIDE-REFRACTORY MULTIPLE MYELOMA AND 1–3 PRIO... by R. Mina, M. Vogel, N.W.C.J. Van De Donk, J. Martínez-López, B. Dhakal, M. Dutka, L. Shune, C. Touzeau, X. Leleu, Y.C. Cohen, W. Alsdorf, K. Li, M. Zhao, Q. Li, A. Ghosh, N. Lendvai, A. Slaughter, C. Lonardi, V. Plaks, M. Koneru, N. Patel, E. Florendo, A. Oriol, R. Popat, P.J. Ho

    Published in Haematologica (2025-09-01)
    Get full text
    Article


  4. 4

    P1573: VARIATION IN USE OF IMMUNOGLOBULIN AND IMPACT ON SURVIVAL IN MULTIPLE MYELOMA: A REPORT FROM THE AUSTRALIA/NEW ZEALAND (ANZ) AND ASIA-PACIFIC (APAC) MYELOMA AND RELATED DISE... by K. L. Chai, C. Wellard, N. Aoki, E. M. Moore, B. Augustson, A. Bapat, H. A. Blacklock, W. J. Chng, R. Cooke, C. Forsyth, N. Hamad, S. J. Harrison, P. J. Ho, J. Hocking, I. H. Kerridge, J. S. Kim, K. Kim, T. King, G. J. McCaughan, P. Mollee, C. O. Morrissey, N. Murphy, H. Quach, X. N. Tan, A. Tso, K. Wong, A. Spencer, E. M. Wood, Z. K. McQuilten

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  5. 5

    B07 | LONG-TERM CLINICAL OUTCOMES WITH TISAGENLECLEUCEL IN HIGH-RISK RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: 4-YEAR FOLLOW-UP FROM THE PHASE 2 ELARA STUDY by P.L. Zinzani, C. Thieblemont, M. Dreyling, M.J. Dickinson, J. Martínez-Lopez, A. Kolstad, J. Butler, M. Ghosh, L.L. Popplewell, J.C. Chavez, E. Bachy, K. Kato, H. Harigae, M.J. Kersten, C. Andreadis, P.A. Riedell, P.J. Ho, J.A. Pérez-Simón, A. Chen, L. Nastoupil, B. Von Tresckow, A.J.M. Ferreri, T. Teshima, P.E.M. Patten, J.P. Mcguirk, F. Offner, A. Viardot, R. Malladi, A. Zia, R. Awasthi, D. Germano, R.J. Ramos, P. Hsu, S.J. Schuster, N.H. Fowler

    Published in Haematologica (2025-09-01)
    Get full text
    Article


Search Tools: